Safety of Intravenous Lidocaine Infusions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01091935|
Recruitment Status : Completed
First Posted : March 24, 2010
Last Update Posted : March 24, 2010
|Condition or disease|
Adults > 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009.
Outcome measures: All side effects spontaneously reported. Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes.
Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.
|Study Type :||Observational|
|Actual Enrollment :||70 participants|
|Official Title:||Safety of Intravenous Lidocaine Infusions for Chronic Neuropathic Pain|
|Study Start Date :||June 2009|
|Primary Completion Date :||January 2010|
|Study Completion Date :||January 2010|
Adults >18 yrs , attending St Joseph's Health Care Pain Clinic with a diagnosis of chronic neuropathic pain who are being treated with an lidocaine infusion of 5 mg/kg over 45 minutes
Consecutive patients from two time periods:
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01091935
|St Joseph's Health Care|
|London, Ontario, Canada, N6A 4V2|
|Principal Investigator:||Patricia K Morley-Forster, MD, FRCPC||Associate Professor,Dept of Anesthesia and Perioperative Medicine,University of Western Ontario, Lawson Health Research Institute|
|Principal Investigator:||Patricia K Morley-Forster, MD, FRCPC||Associate Professor, University of Western Ontario, Lawson Health Research Institute|